Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status

Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2) induced Coronavirus Disease - 19 (COVID-19) cases have been increasing at an alarming rate (7.4 million positive cases as on June 11 2020), causing high mortality (4,17,956 deaths as on June 11 2020) and economic loss (a 3.2% shrink in gl...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Immunol
Main Authors: Beeraka, Narasimha M., Sadhu, Surya P., Madhunapantula, SubbaRao V., Rao Pragada, Rajeswara, Svistunov, Andrey A., Nikolenko, Vladimir N., Mikhaleva, Liudmila M., Aliev, Gjumrakch
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2020
Assuntos:
Immunology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7531039/
https://ncbi.nlm.nih.gov/pubmed/33072093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.552925
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares